Sign in

BridgeBio Oncology Therapeutics, Inc.

Dec-25 Dec-24 Dec-23 Dec-22 Dec-21
Total revenue 0.00 0.00 0.00
Cost of revenue 0.00
Gross profit 0.00
Total operating expenses + 0.15 0.08 0.06 0.00 0.00
Operating income -0.15 -0.08 -0.06 0.00 0.00
Non-operating income (net) 0.01 0.01 0.00 0.00 0.00
Income before tax -0.13 -0.07 -0.06 0.00 0.00
Net income -0.13 -0.07 -0.06 0.00 0.00
Show Quarterly Income Statement
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Dec-22
Total revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cost of revenue 0.00 0.00 0.00
Gross profit 0.00 0.00 0.00
Total operating expenses + 0.05 0.04 0.05 0.03 0.02 0.02 0.02 0.02 0.02 0.00 0.00
Operating income -0.05 -0.04 -0.05 -0.03 -0.02 -0.02 -0.02 -0.02 -0.02 0.00 0.00
Non-operating income (net) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Income before tax -0.04 -0.04 -0.04 -0.03 -0.02 -0.02 -0.02 -0.02 -0.02 0.00 0.00
Net income -0.04 -0.04 -0.04 -0.03 -0.02 -0.02 -0.02 -0.02 -0.02 0.00 0.00
5 days ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21
Total cash and short-term investments + 0.43 0.13 0.00 0.00 0.00
Accounts receivable, net 0.00
Other current assets 0.00 0.00 0.00
Total current assets 0.43 0.00 0.00
Total non-current assets + 0.02 0.19 0.00 0.00 0.00
Total assets 0.45 0.19 0.00 0.00 0.00
Total current liabilities + 0.04 0.00 0.00 0.00 0.00
Total non-current liabilities + 0.00 0.01 0.10
Total liabilities 0.04 0.01 0.00 0.00 0.00
Total stockholders' equity + 0.41 0.19 0.00 0.00 0.00
Common shares outstanding 31 17 20 20 20
Show Quarterly Balance Sheet
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22
Total cash and short-term investments + 0.25 0.43 0.47 0.13 0.14 0.13 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts receivable, net 0.00 0.00 0.00 0.00 0.00
Other current assets 0.01 0.00 0.01 0.01 0.01 0.00 0.00 0.00 0.00
Total current assets 0.27 0.43 0.48 0.14 0.14 0.00 0.00 0.00 0.00
Total non-current assets + 0.15 0.02 0.01 0.01 0.01 0.19 0.19 0.19 0.19 0.00 0.00 0.00
Total assets 0.42 0.45 0.48 0.15 0.15 0.19 0.19 0.19 0.19 0.00 0.00 0.00
Total current liabilities + 0.04 0.04 0.04 0.03 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total non-current liabilities + 0.00 0.00 0.00 0.35 0.33 0.01 0.01 0.01 0.01
Total liabilities 0.05 0.04 0.04 0.38 0.35 0.01 0.01 0.01 0.01 0.00 0.00 0.00
Total stockholders' equity + 0.37 0.41 0.45 -0.23 -0.20 0.19 0.19 0.18 0.18 0.00 0.00 0.00
Common shares outstanding 31 31 24 24 24 17 24 24 22 20 20 20 20 20
5 days ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21
Operating cash flow + -0.11 0.00 -0.05
Cash flow from investing + 0.07 -0.18
Cash flow from financing + 0.38 0.19 0.06
Change in cash 0.34 0.00 0.00 0.00 0.00
Show Quarterly Cash Flow
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Dec-22
Operating cash flow + -0.04 -0.04 -0.07 -0.02 0.00 0.00 -0.04 0.00 -0.01
Cash flow from investing + -0.29 0.01 0.07 0.01 0.04 0.00
Cash flow from financing + 0.00 0.00 0.38 0.02 0.00 0.00 0.02 0.20 0.01
Change in cash -0.32 -0.04 0.38 0.01 0.00 0.00 0.02 0.20 0.00 0.00 0.00
5 days ago

BridgeBio Oncology Therapeutics, Inc. (BBOT) - Retained Earnings

1Y 2Y 5Y Max
9 days ago

BridgeBio Oncology Therapeutics, Inc. (BBOT) - Total Shareholder Equity

1Y 2Y 5Y Max
9 days ago

BridgeBio Oncology Therapeutics, Inc. (BBOT) - Other Current Liabilities

1Y 2Y 5Y Max
9 days ago

BridgeBio Oncology Therapeutics, Inc. (BBOT) - Short Long Term Debt Total

1Y 2Y 5Y Max
9 days ago

BridgeBio Oncology Therapeutics, Inc. (BBOT) - Capital Lease Obligations

1Y 2Y 5Y Max
9 days ago

BridgeBio Oncology Therapeutics, Inc. (BBOT) - Total Non Current Liabilities

1Y 2Y 5Y Max
9 days ago

BridgeBio Oncology Therapeutics, Inc. (BBOT) - Short Term Debt

1Y 2Y 5Y Max
9 days ago

BridgeBio Oncology Therapeutics, Inc. (BBOT) - Current Accounts Payable

1Y 2Y 5Y Max
9 days ago

BridgeBio Oncology Therapeutics, Inc. (BBOT) - Total Current Liabilities

1Y 2Y 5Y Max
9 days ago

BridgeBio Oncology Therapeutics, Inc. (BBOT) - Total Liabilities

1Y 2Y 5Y Max
9 days ago